1. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001; 18: 260-273. [
DOI:10.1159/000050149]
2. Muller SA, Treutner KH, Haase G, Kinzel S, Tietze L, Schumpelick V. Effect of intera peritonealanti adhesive fluids in a rat peritonitis model. Archsurg 2003; 138: 286-290. [
DOI:10.1001/archsurg.138.3.286]
3. Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents forpreventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2000; 2: CD000475.
4. Sekiba K. Use of Interceed (TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. Obstet Gynecol 1992; 79: 518-522.
5. Burd DA, Greco RM, Regauer S, Longaker MT, Siebert JW, Garg HG. Hyaluronan and wound healing: a newperspective. Br J PlastSurg 1991; 44: 579-584. [
DOI:10.1016/0007-1226(91)90093-Y]
6. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intra peritoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9-12. [
DOI:10.1080/107175401300002694]
7. Dizerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17:1031-1038. [
DOI:10.1093/humrep/17.4.1031]
8. Roman H, Canis M, Kamble M, Botchorishvili R, Pouly JL, Mage G. Efficacy of three adhesion preventive agent in reducing severe peritoneal truma induced in a laparoscopic rat model. Fertil Steril 2005; 83: 1113-1118. [
DOI:10.1016/j.fertnstert.2004.08.039]
9. Muller SA, Treutner KH, Jorn H, Anurov M, Ottinger AP, Schumpelick V. Adhesion prevention comparing liquid and solid barriers in the rabbit uterine horn model. Eur J Obstet Gynecol Reprod Biol 2005; 120: 222-226. [
DOI:10.1016/j.ejogrb.2004.09.011]
10. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2006; 19: CD001298. [
DOI:10.1002/14651858.CD001298.pub3]
11. Saedon M, Borowski DW, Natu S, Hennessy C, Tabaqchali MA. David W Borowski, SonaliNatu, Colm Hennessy. Adept (Icodextrin 4%): A tale of caution. Colorectal Dis 2010; 12: 384-386. [
DOI:10.1111/j.1463-1318.2009.02007.x]
12. Reichel W, Schulze B, Dietze J, Mende W. A case of sterile peritonitis associated with icodextrin solution. Perit Dial Int 2001; 21: 414-419.
13. Kamffer WJ, Jooste EV, Nel JT, de Wet JI. Surgical glove powder and intraperitoneal adhesion formation. An appeal for the use of powder-free surgical gloves. S Afr Med J 1992; 81: 158-159.
14. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Dis 2002; 4: 355-360. [
DOI:10.1046/j.1463-1318.2002.00374.x]
15. Lower AM, Hawthorn RJS, Ellis H, O'Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: anassessment from the SurgicalandClinical Adhesions Research Study. Br J Obstet Gynaecol 2000; 107: 855-862. [
DOI:10.1111/j.1471-0528.2000.tb11083.x]
16. Lower AM, Hawthorn RJS, Clark D, Boyd JH, Finlayson AR, Knight AD, et al. Adhesionrelated readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24,046 patients. Hum Reprod 2004; 19: 1877-1885. [
DOI:10.1093/humrep/deh321]
17. Rimbach S, Korell M, Tinneberg HR, DeWilde RL. Adhesions and their prevention in gynaecologic surgery: current status and consensus based on four workshops. Geburtsh Frauenheilk 2004; 64: 891-899. [
DOI:10.1055/s-2004-821239]
18. Lancey JT. The prevention of peritoneal adhesions by amniotic fluid. Ann Surg 1930; 92: 281-293. [
DOI:10.1097/00000658-193008000-00014]
19. Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, et al. Studies in fetal wound healing. IV. Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Ann Surg 1989; 667-672. [
DOI:10.1097/00000658-198911000-00016]
20. Johns DB, Keyport GM, Hoehler F, diZerega GS; Intergel Adhesion Prevention Study Group. Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertil Steril 2001; 76: 595-604. [
DOI:10.1016/S0015-0282(01)01954-9]
21. Lundorff P, Geldorp H, Tronstad SE, Lalos O, Larsson B, Johns DB, et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Hum Reprod 2001; 16: 1982-1988. [
DOI:10.1093/humrep/16.9.1982]
22. Pellicano M, Bramante S, Cirillo D, Palomba S, Bifulco G, Zullo F, et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril 2003; 80: 441-444. [
DOI:10.1016/S0015-0282(03)00597-1]
23. Rodgers KE, Verco SJS, diZerega GS. Effects of intraperitoneal 4% icodextrin solution onthe healing of bowel anastomoses and laparotomy incisions in rabbits. Colorectal Dis 2003; 5: 324-330. [
DOI:10.1046/j.1463-1318.2003.00447.x]
24. Flessner MF, Lofthouse J. Of mice and men: species and age difference in dialysis withicodextrin. J Am Soc Nephrol 1999; 10: 226A.
25. Verco SJS, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesionprevention: pre-clinicalstudies. Hum Reprod 2000; 15: 1764-1772. [
DOI:10.1093/humrep/15.8.1764]
26. Rodgers KE, Verco SJ, diZerega GS. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbit. Colorectal Dis 2003; 5: 324-330. [
DOI:10.1046/j.1463-1318.2003.00447.x]
27. Santos LM, Frenna V, Thoma V, Wattiez A. Disseminated intravascular coagulation after laparoscopic multiple myomectomy with use of icodextrin. J Minim Invasive Gynecol 2006: 13, 480-482. [
DOI:10.1016/j.jmig.2006.05.013]
28. Doumplis D, Majeed GS, Sieunarine k, Richardson R, Smith JR. Adverse effects related to icodextrin 4% our experience.Gynecol Surg 2007; 4: 97-100. [
DOI:10.1007/s10397-006-0267-0]
29. Catena F, Ansaloni L, Lauro A, Ercolani G, D'Alessandro L, Pinna A. Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences. Trials 2008; 9: 74. [
DOI:10.1186/1745-6215-9-74]
30. Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS, et al. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007; 88: 1413-1426. [
DOI:10.1016/j.fertnstert.2006.12.084]